It is a common perception that approximately 50% of heart failure (HF) patients present with a normal or near-normal left ventricular (LV) ejection fraction ("HF with preserved systolic function"), ...

Following the course of lung function in treatment-naïve patients, researchers found that lung function decline does not accelerate prior to mechanical ventilation. Patterns in the decline of lung ...

Current models of mortality risk after heart failure (HF) rely primarily on cardiac-specific clinical variables and may underestimate risk in elderly East Asian patients. Researchers from Japan used ...

Researchers at the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, and the University of Utah School of Medicine, have demonstrated that a gene therapy can ...

A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...

NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection fraction improved cardiac function and reduced the risks for serious medical ...

Juntendo University researchers have trained a machine learning algorithm to use clinical information and physical function metrics to accurately estimate long-term survival odds of elderly patients ...

Kidney failure is a serious medical condition that can affect many parts of the body and become life-threatening if not ...

During embryonic development, the right ventricle is formed from the secondary heart field into a crescent-shaped, thin-walled structure. 6 It is the most anterior heart chamber, sitting just beneath ...

After a heart attack, the heart struggles to recoup and maintain energy. One third of patients develop heart failure as a result ⎯ a condition that impacts 6.8 million Americans and carries a high ...

A new blood test can identify which individuals of African ancestry carrying high-risk APOL1 gene variants are most likely to develop kidney failure, years before clinical disease becomes apparent.